Germany· DE-A57-a848adfaa168f200
Cor Suis Compositum N
A medicinal product, registered in Germany by Biologische Heilmittel Heel Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Manufacturer
- Biologische Heilmittel Heel Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c864f9d9-5ee7-4cdf-8c36-c46a04f76287 GET /v1/drugs/c864f9d9-5ee7-4cdf-8c36-c46a04f76287?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use, Intravenous Use, Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Strychnos Ignatii Dil. D 6, Arnica Montana Dil. D4, Nitroglycerinum Dil. D4, Kalmia Latifolia Dil. D4, Kalium Carbonicum Dil. D4, Selenicereus Grandiflorus Dil. D30, Spigelia Anthelmia Dil. D10, Crataegus Dil. D6, Carbo Vegetabilis Dil. D18, Ranunculus Bulbosus Dil. D6, Acidum Alpha-Ketoglutaricum D8, Acidum Fumaricum D8, Sarcolacticum Acidum D6, Acidum Malicum D8, Cor Suis D8, Hepar Suis D8, Natrium Diethyloxalaceticum D8, Ouabainum D8, Acidum Arsenicosum Dil. D8",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about Cor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.